{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:38:23Z","timestamp":1787017103798,"version":"build-2736575974"},"reference-count":53,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/501100001183","name":"Crawford Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004817","name":"Lund University Medical Faculty Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004200","name":"Stiftelsen Olle Engkvist Byggm\u00e4stare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2017,10,25]]},"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Neoadjuvant treatment has now become the standard of care for oesophageal and gastric cancer. The aim of this study was to investigate the influence of neoadjuvant therapy on the expression of human epidermal growth factor receptor 1 (HER1\/EGFR), HER2 and HER3, in oesophageal and gastric adenocarcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Immunohistochemical expression of EGFR, HER2 and HER3 was examined and compared in pretreatment biopsies, post-treatment surgical resection specimens and metastases in a retrospective cohort of 166 patients with adenocarcinoma of the oesophagus or stomach. The relationship between expression of the investigative markers and histopathological response to neoadjuvant treatment, overall survival (OS) and recurrence free survival (RFS) was analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Conversion of protein expression between pretreatment biopsy and post-treatment surgical resection was seen in 4.6% of the cases for EGFR, 5.9% for HER2% and 19.4% for HER3. Histopathological response to neoadjuvant treatment was significantly and stepwise associated with OS and RFS . High HER3 protein expression in post-treatment surgical resection specimens was significantly associated with a prolonged OS in univariable analysis (HR=0.39; 95% CI 0.17 to 0.93), but did not remain significant in multivariable analysis. Expression of EGFR and HER2 in post-treatment surgical resection specimens was not prognostic. No correlation between pretreatment HER-protein expression and histopathological response was seen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results from this study underscore the need for further studies on the influence of neoadjuvant treatment on biomarker expression, as this may influence treatment strategy as well as prognosis. Histopathological response is validated as a useful prognostic factor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jclinpath-2017-204774","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T12:15:37Z","timestamp":1510661737000},"page":"451-462","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment"],"prefix":"10.1136","volume":"71","author":[{"given":"Charlotta","family":"Hedner","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9461-7391","authenticated-orcid":false,"given":"David","family":"Borg","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Nodin","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelie","family":"Karnevi","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Jirstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Eberhard","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"2025092509234615000_71.5.451.1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24290"},{"key":"2025092509234615000_71.5.451.2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210"},{"key":"2025092509234615000_71.5.451.3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23232"},{"key":"2025092509234615000_71.5.451.4","unstructured":"Global cancer facts & figures. 2nd edn. http:\/\/www.cancer.org\/acs\/groups\/content\/@epidemiologysurveilance\/documents\/document\/acspc-027766.pdf"},{"key":"2025092509234615000_71.5.451.5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semradonc.2012.09.008","article-title":"Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease","volume":"23","author":"Buas","year":"2013","journal-title":"Semin Radiat Oncol"},{"key":"2025092509234615000_71.5.451.6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603910"},{"key":"2025092509234615000_71.5.451.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1609"},{"key":"2025092509234615000_71.5.451.8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs501"},{"key":"2025092509234615000_71.5.451.9","doi-asserted-by":"publisher","DOI":"10.1038\/35052073"},{"key":"2025092509234615000_71.5.451.10","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4254"},{"key":"2025092509234615000_71.5.451.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103153441101"},{"key":"2025092509234615000_71.5.451.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052306"},{"key":"2025092509234615000_71.5.451.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61094-6"},{"key":"2025092509234615000_71.5.451.14","first-page":"25","article-title":"HER2 status in Barrett\u2019s esophagus & esophageal cancer: a meta analysis","volume":"5","author":"Gowryshankar","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"2025092509234615000_71.5.451.15","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2011-0168-RS"},{"key":"2025092509234615000_71.5.451.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61121-X"},{"key":"2025092509234615000_71.5.451.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2008.03028.x"},{"key":"2025092509234615000_71.5.451.18","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12359"},{"key":"2025092509234615000_71.5.451.19","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-100103852"},{"key":"2025092509234615000_71.5.451.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148101","article-title":"Expression and prognostic significance of human epidermal growth factor receptors 1 and 3 in gastric and esophageal adenocarcinoma","volume":"11","author":"Hedner","year":"2016","journal-title":"PLoS One"},{"key":"2025092509234615000_71.5.451.21","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.205"},{"key":"2025092509234615000_71.5.451.22","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt393"},{"key":"2025092509234615000_71.5.451.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2010.08.007"},{"key":"2025092509234615000_71.5.451.24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.6313"},{"key":"2025092509234615000_71.5.451.25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.arcmed.2013.07.001","article-title":"Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis","volume":"44","author":"Chen","year":"2013","journal-title":"Arch Med Res"},{"key":"2025092509234615000_71.5.451.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153533","article-title":"Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in periampullary adenocarcinoma","volume":"11","author":"Elebro","year":"2016","journal-title":"PLoS One"},{"key":"2025092509234615000_71.5.451.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-009-0702-6"},{"key":"2025092509234615000_71.5.451.28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00428-015-1747-2","article-title":"HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value","volume":"466","author":"Seo","year":"2015","journal-title":"Virchows Arch"},{"key":"2025092509234615000_71.5.451.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112088"},{"key":"2025092509234615000_71.5.451.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055531"},{"key":"2025092509234615000_71.5.451.31","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt342"},{"key":"2025092509234615000_71.5.451.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.09.020"},{"key":"2025092509234615000_71.5.451.33","unstructured":"Esofagus- ochventrikelcancer. http:\/\/www.cancercentrum.se\/globalassets\/cancerdiagnoser\/matstrupe-och-magsack\/vardprogram\/natvp-esofagus-ventrikelcancer-121121.pdf"},{"key":"2025092509234615000_71.5.451.34","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25537"},{"key":"2025092509234615000_71.5.451.35","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20916"},{"key":"2025092509234615000_71.5.451.36","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.198"},{"key":"2025092509234615000_71.5.451.37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10120-015-0502-3","article-title":"Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer","volume":"19","author":"Tominaga","year":"2016","journal-title":"Gastric Cancer"},{"key":"2025092509234615000_71.5.451.38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1517\/13543784.2013.761972","article-title":"Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers","volume":"22","author":"Desai","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"2025092509234615000_71.5.451.39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1318"},{"key":"2025092509234615000_71.5.451.40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/his.12744","article-title":"Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis","volume":"68","author":"Hedner","year":"2016","journal-title":"Histopathology"},{"key":"2025092509234615000_71.5.451.41","first-page":"772-8","article-title":"Heterogeneity and cancer","volume":"28","author":"Allison","year":"2014","journal-title":"Oncology"},{"key":"2025092509234615000_71.5.451.42","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.36"},{"key":"2025092509234615000_71.5.451.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.04.012"},{"key":"2025092509234615000_71.5.451.44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138336","article-title":"ERBB3 Positively correlates with intestinal stem cell markers but marks a distinct non proliferative cell population in colorectal cancer","volume":"10","author":"Jard\u00e9","year":"2015","journal-title":"PLoS One"},{"key":"2025092509234615000_71.5.451.45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1016140108"},{"key":"2025092509234615000_71.5.451.46","doi-asserted-by":"publisher","DOI":"10.1126\/science.1141478"},{"key":"2025092509234615000_71.5.451.47","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21782"},{"key":"2025092509234615000_71.5.451.48","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0097"},{"key":"2025092509234615000_71.5.451.49","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-010-0952-2"},{"key":"2025092509234615000_71.5.451.50","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800085"},{"key":"2025092509234615000_71.5.451.51","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds528"},{"key":"2025092509234615000_71.5.451.52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00892.x"},{"key":"2025092509234615000_71.5.451.53","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63075-1"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2017-204774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:23:57Z","timestamp":1758817437000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2017-204774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,18]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/jclinpath-2017-204774"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2017-204774","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]}}}